Inovio Pharmaceuticals, Inc. (INO) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $6.68, up from yesterday’s close by 3.09%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
It’s important to get a feel for how any stock is actually valued on the market based on its core numbers. Inovio Pharmaceuticals, Inc. (INO) currently trades with a market capitalization of $599.80 Million.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For INO, the company currently has $23.86 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $-71.87 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $-0.24 on a per share basis this quarter. Perhaps, that suggests something about why 24.28% of the outstanding share supply is held by institutional investors.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, Inovio Pharmaceuticals, Inc. recorded a 52-week high of $9.86. It is now trading 3.18% off that level. The stock is trading $5.87 its 50-day moving average by -0.81%. The stock carved out a 52-week low down at $5.28.
In recent action, Inovio Pharmaceuticals, Inc. (INO) has made a move of +9.87% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 17.45, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 10.21% with $84.83 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of INO.